Andrew P. Rocks

His clients range from Fortune 500 companies to private equity funds and their portfolio companies to entrepreneurs and emerging businesses across many industries, including technology, retail, consulting, manufacturing, pharmaceutical, healthcare, and energy. Andrew represents many of his clients, including emerging companies and portfolio companies of his private equity clients, through their entire life cycle, guiding these clients through the negotiation and implementation of employment arrangements, incentive equity plans, and other start-up matters, equity and debt financings, corporate restructurings, and sale transactions. 

He routinely advises on complicated transaction structures involving pre-transaction restructurings, equity rollover components, the use of representations and warranties insurance, and earnouts, among other things, on behalf of both buy-side and sell-side clients. Prior to joining Morgan Lewis, Andrew was an associate in the New York office of another major international law firm.

• Represented PTC Therapeutics, Inc. in its acquisition of Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of a clinical-stage investigational therapy for orphan metabolic diseases
• Represented LifeShield, a home security provider and a portfolio company of Hawk Capital, in its $25 million sale to ADT
• Represented BP Products North America in its joint acquisition with ArcLight Capital Partners LLC of all of the outstanding shares of Thorntons Inc., a gasoline and convenience store chain with more than 190 locations in Florida, Illinois, Indiana, Kentucky, Ohio and Tennessee.
• Represented Harte Hanks in the $112 million sale of its Trillium Software business to Clearlake Capital Group, L.P. backed Syncsort Incorporated
• Represented Health Net, Inc. in its $6.8 billion sale to Centene Corporation
• Represented Campbell Soup Company in its $231 million acquisition of Garden Fresh Gourmet